World's Best Scientists 2026 revealed!
Clinical Microbiology Newsletter
H-index 4

Clinical Microbiology Newsletter

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Microbiology 274 12 11 4

Additional Metrics

Number of Best Scientists*: 13
Documents by Best Scientists*: 11
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 28
SCIMAGO SJR: 0.431
Impact Factor: N/A

Overview

Top Research Topics at Clinical Microbiology Newsletter?

The journal investigates studies in Microbiology, Virology, Immunology, Intensive care medicine and Clinical microbiology. Bacteremia is a focus of the Microbiology works in it. Discussions in the journal are anchored in the subject of Immunology and the similar topic of Disease.

  • Microbiology (35.65%)
  • Virology (10.56%)
  • Immunology (9.02%)

What are the most cited papers published in the journal?

  • Development of in vitro susceptibility testing criteria and quality control parameters (326 citations)
  • Verification and Validation of Procedures in the Clinical Microbiology Laboratory (132 citations)
  • Emerging Campylobacter spp.: the Tip of the Iceberg (108 citations)

Research areas of the most cited articles at Clinical Microbiology Newsletter:

The published articles explore disciplines such as Microbiology, Immunology, Antimicrobial, Clinical microbiology and Virology. The journal articles hold forums on Microbiology that merge themes from other disciplines such as Flora (microbiology) and Staphylococcus aureus. In addition to Immunology research, the journal papers aim to explore topics under Intensive care medicine, Disease and Virulence.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Bacteria

The previous edition focused in particular on these issues:

Clinical Microbiology Newsletter focuses on Intensive care medicine, Microbiology, Clinical microbiology, Antibiotic resistance and Virology. The journal explores issues in Intensive care medicine which can be linked to other research areas like Infectious disease (medical specialty), Infectious risk and Antimicrobial stewardship. Clinical Microbiology Newsletter facilitates discussions on Microbiology that incorporate concepts from other fields like Hospital pharmacy, Salmonella and Biopharmaceutical.

It investigates Clinical microbiology research which frequently intersects with Engineering ethics. While work presented in the journal provided substantial information on Antibiotic resistance, it also covered topics in Antimicrobial, Bioinformatics and DNA gyrase. In addition to Virology research, Clinical Microbiology Newsletter aims to explore topics under Pathogen, Reverse transcriptase, Genome and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The most cited articles from the last journal are:

  • Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19 (10 citations)
  • Q Fever: A Troubling Disease and a Challenging Diagnosis (1 citations)
  • Severe Acute Respiratory Syndrome Coronavirus 2: The Emergence of Important Genetic Variants and Testing Options for Clinical Laboratories (1 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Clinical Microbiology Newsletter (based on the number of publications) are:

  • Paul A. Granato (27 papers) absent at the last edition,
  • Alice S. Weissfeld (26 papers) published 1 paper at the last edition,
  • J. Michael Janda (20 papers) absent at the last edition,
  • William M. Janda (18 papers) absent at the last edition,
  • Russell A. Rawling (17 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical Microbiology Newsletter (based on the number of publications) are:

  • Centers for Disease Control and Prevention (57 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Harvard University (48 papers) absent at the last edition,
  • State University of New York Upstate Medical University (35 papers) absent at the last edition,
  • Mayo Clinic (28 papers) published 4 papers at the last edition, 1 more than at the previous edition,
  • University of Chicago (23 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 40.00% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 53.33% were posted by at least one author from the top 10 institutions publishing in the journal. Another 26.67% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 0.00% of all publications and 20.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19

    Juan G. Ripoll;Noud van Helmond;Jonathon W. Senefeld;Chad C. Wiggins

    (2021)
    37 Citations
  • Azole-Resistant Aspergillus fumigatus: What You Need To Know

    Shawn R. Lockhart;Karlyn Beer;Mitsuru Toda

    (2020)
    11 Citations
  • The Fluoroquinolones: An Update for the Clinical Microbiologist

    Alexander S. Maris;Perceus Mody;Donna J. Brewer;Romney M. Humphries

    (2021)
    10 Citations
  • Mycology of Onychomycosis

    (2023)
    4 Citations
  • Leptospiral Infections in Humans

    David A. Haake;Renee L. Galloway

    (2021)
    3 Citations
  • The Molecular Technology Revolution and Bacterial Identification: Unexpected Consequences for Clinical Microbiologists

    (2023)
    3 Citations
  • Clinical Decisions: Detecting Vibriosis in the Modern Era

    J. Michael Janda

    (2020)
    3 Citations
  • An Update on Schistosomiasis

    (2023)
    2 Citations
  • How To Successfully Design and Implement a Clinical Trial To Evaluate the Clinical Impact of New Diagnostic Assays for Testing Positive Blood Culture Bottles

    (2021)
    0 Citations
  • A 21st Century Appraisal of Whipple’s Disease and Tropheryma whipplei

    (2022)
    0 Citations

Best Scientists Contributing to This Journal

Recently Published Articles